Poised to be one of the latest generation ventricular assist devices (VADs) to win FDA approval is the HeartMate II from Thoratec (Pleasanton, California). The company featured the device during the Scientific Sessions of the Heart Failure Society of America (St. Paul, Minnesota) by making available at its exhibit area two real-life case studies: two people implanted with the device.